Gonorrhoea treatment combined with population-level general cephalosporin and quinolone consumption may select for Neisseria gonorrhoeae antimicrobial resistance at the levels of NG-MAST genogroup: An ecological study in Europe.

Journal of Global Antimicrobial Resistance
Chris KenyonMagnus Unemo

Abstract

The prevalence of Neisseria gonorrhoeae NG-MAST genogroup G1407, associated with decreased susceptibility to extended-spectrum cephalosporins and fluoroquinolone resistance, has declined in Europe and it switched from circulating predominantly in men who have sex with men (MSM) in 2009-2010 to heterosexuals in 2013. We hypothesise that changes to gonorrhoea treatment guidelines combined with differences in country-level consumption of cephalosporins and quinolones contributed to this shift. Linear regression was used to evaluate the association between changes in prevalence of G1407 between 2009-2010 and 2013 and country-level consumption of quinolones and cephalosporins in 2011/12 in 20 European countries. Whilst the prevalence of G1407 declined between 2009-2010 and 2013 in the EU/EEA, its absolute prevalence increased by 10% or more in three countries. The national prevalence of G1407 in 2013 was positively associated with population-level general cephalosporin and quinolone consumption in the preceding 2 years. The association between the prevalence of G1407 and proportion of the national sample derived from MSM was non-significant in 2009-2010 and was negative in 2013. Our results are broadly compatible with the hypothesis...Continue Reading

References

Jun 2, 1979·British Medical Journal·J Wallin, M S Siegel
Apr 17, 2002·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Masatoshi TanakaSeiji Naito
Sep 18, 2004·British Journal of Clinical Pharmacology·R H Vander SticheleUNKNOWN ESAC Project Group
Sep 9, 2009·Expert Review of Anti-infective Therapy·John W TapsallMagnus Unemo
Aug 10, 2010·The Journal of Antimicrobial Chemotherapy·Stephanie A ChisholmDavid M Livermore
Oct 15, 2011·International Journal of STD & AIDS·C BignellUNKNOWN British Association for Sexual Health and HIV UK
Dec 13, 2012·Future Microbiology·Magnus Unemo, Robert A Nicholas
Jan 9, 2014·International Journal of STD & AIDS·C BignellUNKNOWN European STI Guidelines Editorial Board
Jul 16, 2016·MMWR. Surveillance Summaries : Morbidity and Mortality Weekly Report. Surveillance Summaries·Robert D KirkcaldyElizabeth Torrone
Feb 9, 2017·Sexually Transmitted Diseases·Mitsuru YasudaTakashi Deguch
May 26, 2017·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·Julien BeautéGianfranco Spiteri
Sep 21, 2017·Emerging Infectious Diseases·Robert D KirkcaldyLauri A Hicks
May 20, 2018·The Lancet Infectious Diseases·Simon R HarrisUNKNOWN Euro-GASP study group
Sep 22, 2018·The Journal of Infectious Diseases·Scott W OlesenYonatan H Grad
Dec 19, 2018·Proceedings of the National Academy of Sciences of the United States of America·Christine TedijantoMarc Lipsitch
May 3, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Huan V DongJeffrey D Klausner

❮ Previous
Next ❯

Citations

Mar 7, 2021·International Journal of Molecular Sciences·Katarzyna SmolarczykWojciech Pieta

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.